Tailored Non-Pharmacotherapy Services for Chronic Pain
RESOLVE
1 other identifier
interventional
2,333
1 country
4
Brief Summary
The RESOLVE study is a multicenter comparative effectiveness trial of two cognitive behavioral therapy-based chronic pain (CBT-CP) treatments delivered via telehealth modalities: 1) online program and 2) live, health coach-led, virtual sessions (telephone and/or video conference).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Jan 2021
Longer than P75 for not_applicable chronic-pain
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
August 24, 2020
CompletedStudy Start
First participant enrolled
January 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedResults Posted
Study results publicly available
January 22, 2026
CompletedJanuary 22, 2026
January 1, 2026
3.3 years
August 19, 2020
May 1, 2025
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Minimal Clinically Important Difference (MCID) in Pain Severity at 3 Months (Yes / No)
Minimal clinically important difference (MCID) in pain severity is defined as a 30% or greater improvement in pain severity score. \[Pain severity score assessed via modified 11-item version of the Brief Pain Inventory - Short Form (BPI-SF) from baseline (consistent with IMMPACT guidelines). The BPI-SF range= 0 to 10; higher score = worse pain severity.\] MCID outcome is binary; reported as the adjusted percentage of participants with MCID (\> or =30% improvement) in pain severity.
Baseline to 3 months
Secondary Outcomes (9)
MCID in Pain Severity at 6 Months (Yes / No)
Baseline to 6 months
MCID in Pain Severity at 12 Months (Yes / No)
Baseline to 12 months
Pain Severity Score
Baseline to 3, 6 and 12 months
Pain Intensity Score
Baseline to 3, 6, and 12 months
Pain-related Interference Score
Baseline to 3, 6 and 12 months
- +4 more secondary outcomes
Study Arms (3)
Online CBT-CP based program
ACTIVE COMPARATORSelf-completed, online program in which participants complete eight, interactive sessions (approximately one per week) focused on training in one or more evidence-based pain coping skills (no usual care services restricted)
Virtual health coach-led CBT-CP based program
ACTIVE COMPARATORLive, health coach-led program delivered by telephone or videoconference in which participants complete eight, interactive sessions (approximately one per week) focused on training in one or more evidence-based pain coping skills (no usual care services restricted)
Usual Care plus information
NO INTERVENTIONReceipt of a bound copy of the 2020 edition of the American Chronic Pain Association Resource Guide to Chronic Pain Management and any pharmacologic and nonpharmacologic treatments available to them without restriction
Interventions
Live, health coach-led program delivered by telephone or videoconference in which participants complete eight, interactive sessions (approximately one per week) focused on training in one or more evidence-based pain coping skills
Self-completed, online program in which participants complete eight, interactive sessions (approximately one per week) focused on training in one or more evidence-based pain coping skills
Eligibility Criteria
You may qualify if:
- Active/enrolled in one of the 4 participating integrated health care systems at the time of query and for the prior 360 days
- Age 18 years or older (based on date of birth documented in EHR)
- English speaking or do not need interpreter services
- Have at least one \[at Essentia\] or at least two which are \>60 days apart \[at KP sites\] outpatient pain-related health care encounter with nonmalignant musculoskeletal pain diagnoses \[as determined by ICD10 codes for any of the following: back-neck-, limb/extremity-, joint-pain, arthritic disorders, fibromyalgia, headache, orofacial/temporomandibular pain, or musculoskeletal pain\] within the past 360 days
- Do not have an encounter for surgery related to common musculoskeletal pain conditions (e.g., joint replacement, spinal fusion, carpal tunnel release surgery) \[as determined by CPT and/or ICD-10 codes\] within the past 60 days
- Do not have two or more separate encounters with a malignant cancer diagnosis other than non-melanoma skin cancer \[as determined by ICD-10 codes\] within past 60 days
- Do not have ICD-10 code(s), Current Procedural Terminology (CPT) code(s) or department/provider encounters indicating receipt of hospice or other palliative care within the past 360 days
- Do not have ICD-10 codes indicating severe cognitive impairment precluding participation in a behavioral/ lifestyle change program
- Have high-impact chronic pain (as indicated by self-report of having pain on most or every day in past 3 months and pain limiting life or work activities on most or every day in past 3 months)
- Have persistent pain (as indicated by self-report Pain, Enjoyment of Life and General Activity (PEG) score of ≥ 12)
- Be able to participate in either of the active interventions (i.e., have internet and phone access required for accessing treatments)
You may not qualify if:
- Have received CBT for pain or pain-related psychoeducation or behavioral skills training within in the past 6 months (in-person, by phone or videoconference, or online)
- Currently receiving or will be starting CBT for pain or pain-related psychoeducation or behavioral skills training in the next month (in-person, by phone or videoconference, or online)
- Currently receiving or will be starting inpatient or intensive outpatient services for substance use disorder in the next month
- Have a planned/scheduled surgery in next 12 months related to pain condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Essentia Healthcollaborator
- Georgia State Universitycollaborator
- Duke Universitycollaborator
- Northwestern Universitycollaborator
Study Sites (4)
Kaiser Permanente Georgia, Center for Research and Evaluation
Atlanta, Georgia, 30309, United States
Essentia Institute of Rural Health
Duluth, Minnesota, 55805, United States
Kaiser Permanente Northwest Center for Health Research
Portland, Oregon, 97227, United States
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, 98101, United States
Related Publications (2)
DeBar LL, Mayhew M, Wellman RD, Balderson BH, Dickerson JF, Elder CR, Justice M, Keefe FJ, McMullen CK, Owen-Smith AA, Rini C, Von Korff M, Waring S, Yarava A, Shen Z, Thompson RE, Clark AE, Casper TC, Cook AJ. Telehealth and Online Cognitive Behavioral Therapy-Based Treatments for High-Impact Chronic Pain: A Randomized Clinical Trial. JAMA. 2025 Jul 23;334(7):592-605. doi: 10.1001/jama.2025.11178. Online ahead of print.
PMID: 40699570BACKGROUNDMayhew M, Balderson BH, Cook AJ, Dickerson JF, Elder CR, Firemark AJ, Haller IV, Justice M, Keefe FJ, McMullen CK, O'Keeffe-Rosetti MC, Owen-Smith AA, Rini C, Schneider JL, Von Korff M, Wandner LD, DeBar LL. Comparing the clinical and cost-effectiveness of remote (telehealth and online) cognitive behavioral therapy-based treatments for high-impact chronic pain relative to usual care: study protocol for the RESOLVE multisite randomized control trial. Trials. 2023 Mar 16;24(1):196. doi: 10.1186/s13063-023-07165-8.
PMID: 36927459BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Meghan Mayhew
- Organization
- Kaiser Permanente
Study Officials
- PRINCIPAL INVESTIGATOR
Lynn L DeBar, PhD, MPH
Kaiser Permanente
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Primary and secondary outcome assessors will be masked to treatment assignment. It is not feasible for participants to be masked to treatment arm assignment due to the type of intervention. The PI and select Co-Investigators and study staff who are involved in the oversight and delivery of the interventions will also be aware of treatment assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2020
First Posted
August 24, 2020
Study Start
January 14, 2021
Primary Completion
April 30, 2024
Study Completion
August 31, 2025
Last Updated
January 22, 2026
Results First Posted
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The database will be released at the time of publication of the primary manuscript, or within 12 months of last patient procedure, whichever comes first. The duration of availability will be in accordance with procedures and regulations of the NIH HEAL Initiative and the project funder (NIA).
- Access Criteria
- Access to the releasable database housed in the NIH-assigned repository will be in accordance with procedures and regulations of the NIH HEAL Initiative and the project funder (NIA).
A releasable database containing underlying Individual Participant Data (IPD) from the primary outcomes manuscript and all National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-term) Initiative common data elements will be produced and made broadly available through the NIH HEAL Initiative-designated central data repository. The database will be completely de-identified in accordance with the definitions provided in the Health Insurance Portability and Accountability Act (HIPAA) and in accordance to the standards set forth in the Department of Health and Human Services Regulations for the Protection of Human Subjects. Namely, all identifiers specified in HIPAA will be recoded in a manner that will make it impossible to deduce or impute the specific identity of any patient. The database will not contain any institutional or healthcare system identifiers.